{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:18:24Z","timestamp":1772119104085,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02892-w","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T08:03:18Z","timestamp":1702540998000},"page":"4355-4364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial"],"prefix":"10.1007","volume":"397","author":[{"given":"Niloufar","family":"Saber-Moghaddam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Moeini","family":"Nodeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad Ataei","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Seddigh-Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Kamandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolghasem","family":"Allahyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh Sadat","family":"Shariatmaghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Elyasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"6928","key":"2892_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/bmj.308.6928.588","volume":"308","author":"MA al-jubouri","year":"1994","unstructured":"al-jubouri MA, Briston PG, Sinclair D, Chinn RH, Young RM (1994) Myxoedema revealed by simvastatin induced myopathy. BMJ 308(6928):588","journal-title":"BMJ"},{"key":"2892_CR2","doi-asserted-by":"publisher","unstructured":"Atilla A, \u00c7elik M, \u00c7olak \u00d6Y, Kuruo\u011flu T, Temo\u00e7in F, Kelkitli E, Birinci A (2022)\u00a0Hematolojik Maligniteli Hastalarda \u0130nvaziv K\u00fcf Enfeksiyonlar\u0131: \u00c7evresel Fakt\u00f6rlerin Etkisi [Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors]. Mikrobiyol Bul 56(2):315\u2013325. https:\/\/doi.org\/10.5578\/mb.20229810","DOI":"10.5578\/mb.20229810"},{"issue":"5","key":"2892_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12185-008-0184-2","volume":"88","author":"J Auberger","year":"2008","unstructured":"Auberger J, Lass-Fl\u00f6rl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D (2008) Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 88(5):508\u2013515","journal-title":"Int J Hematol"},{"issue":"6","key":"2892_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/mus.20135","volume":"30","author":"SK Baker","year":"2004","unstructured":"Baker SK, Goodwin S, Sur M, Tarnopolsky MA (2004) Cytoskeletal myotoxicity from simvastatin and colchicine. Muscle Nerve 30(6):799\u2013802. https:\/\/doi.org\/10.1002\/mus.20135","journal-title":"Muscle Nerve"},{"issue":"2","key":"2892_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","volume":"21","author":"EJ Bow","year":"1995","unstructured":"Bow EJ, Loewen R, Cheang MS, Schacter B (1995) Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 21(2):361\u2013369","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2892_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","volume":"30","author":"ME Cabral","year":"2013","unstructured":"Cabral ME, Figueroa LIC, Fari\u00f1a JI (2013) Synergistic antifungal activity of statin\u2013azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification. Rev Iberoam Micol 30(1):31\u201338","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"2892_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","volume":"50","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP (2006) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother 50(1):96\u2013103","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2892_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1128\/AAC.41.4.850","volume":"41","author":"NX Chin","year":"1997","unstructured":"Chin NX, Weitzman I, Della-Latta P (1997) In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 41(4):850\u2013852","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2892_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/myc.12357","volume":"58","author":"SY Cho","year":"2015","unstructured":"Cho SY, Lee DG, Choi SM, Choi JK, Lee HJ, Kim SH, Park SH, Choi JH, Yoo JH, Kim YJ, Kim HJ, Min WS (2015) Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations. Mycoses 58(9):565\u2013571","journal-title":"Mycoses"},{"issue":"8","key":"2892_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/597395","volume":"48","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dh\u00e9din N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M (2009) Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 48(8):1042\u20131051","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2892_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348\u2013359","journal-title":"N Engl J Med"},{"issue":"5","key":"2892_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/mmy\/myaa071","volume":"59","author":"AS de Oliveira Neto","year":"2021","unstructured":"de Oliveira Neto AS, Souza ILA, Amorim MES, de Freitas Souza T, Rocha VN, do Couto RO, Fabri RL, de Freitas Ara\u00fajo MG (2021) Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis. Med Mycol 59(5):476\u2013485","journal-title":"Med Mycol"},{"issue":"1","key":"2892_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-020-00170-6","volume":"9","author":"Y Dong","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, Wang Q (2020) Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 9(1):14","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2892_CR14","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1080\/10717544.2022.2149898","volume":"29","author":"AS Eita","year":"2022","unstructured":"Eita AS, Makky AMA, Anter A, Khalil IA (2022) Repurposing of atorvastatin emulsomes as a topical antifungal agent. Drug Delivery 29(1):3414\u20133431","journal-title":"Drug Delivery"},{"key":"2892_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000181","volume":"3","author":"K Eljaaly","year":"2017","unstructured":"Eljaaly K, Alshehri S (2017) An updated review of interactions of statins with antibacterial and antifungal agents. J Transl Sci 3:1\u20134. https:\/\/doi.org\/10.15761\/JTS.1000181","journal-title":"J Transl Sci"},{"issue":"4","key":"2892_CR16","first-page":"368","volume":"92","author":"AN Esfahani","year":"2019","unstructured":"Esfahani AN, Golestannejad Z, Khozeimeh F, Dehghan P, Maheronnaghsh M, Zarei Z (2019) Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin. Med Pharm Rep 92(4):368\u2013373","journal-title":"Med Pharm Rep"},{"issue":"1","key":"2892_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5495\/wjcid.v1.i1.4","volume":"1","author":"LN Galg\u00f3czy","year":"2011","unstructured":"Galg\u00f3czy LN, Nyilasi I, Papp T, V\u00e1gv\u00f6lgyi C (2011) Statins as antifungal agents. World J Clin Infect Dis 1(1):4\u201310","journal-title":"World J Clin Infect Dis"},{"issue":"2","key":"2892_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1128\/AAC.01525-13","volume":"58","author":"MZ Gomes","year":"2014","unstructured":"Gomes MZ, Mulanovich VE, Jiang Y, Lewis RE, Kontoyiannis DP (2014) Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrob Agents Chemother 58(2):865\u2013873","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2892_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1567-1364.2006.00097.x","volume":"6","author":"A Gyetvai","year":"2006","unstructured":"Gyetvai A, Emri T, Tak\u00e1cs K, Dergez T, Fekete A, Pesti M, P\u00f3csi I, Lenkey B (2006) Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen. FEMS Yeast Res 6(8):1140\u20138. https:\/\/doi.org\/10.1111\/j.1567-1364.2006.00097.x","journal-title":"FEMS Yeast Res"},{"issue":"6","key":"2892_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.annonc.2020.02.018","volume":"31","author":"M Heuser","year":"2020","unstructured":"Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, Wierzbowska A, Buske C (2020) Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(6):697\u2013712","journal-title":"Ann Oncol"},{"issue":"5","key":"2892_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/jcpt.12425","volume":"41","author":"SH Hsiao","year":"2016","unstructured":"Hsiao SH, Chang HJ, Hsieh TH, Kao SM, Yeh PY, Wu TJ (2016) Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review. J Clin Pharm Ther 41(5):575\u2013578","journal-title":"J Clin Pharm Ther"},{"issue":"S1","key":"2892_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5045\/br.2020.S001","volume":"55","author":"SM Hwang","year":"2020","unstructured":"Hwang SM (2020) Classification of acute myeloid leukemia. Blood Res 55(S1):S1-s4","journal-title":"Blood Res"},{"issue":"4","key":"2892_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1586\/eri.10.16","volume":"8","author":"YY Hwang","year":"2010","unstructured":"Hwang YY, Liang R (2010) Antifungal prophylaxis and treatment in patients with hematological malignancies. Expert Rev Anti Infect Ther 8(4):397\u2013404","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"2892_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11883-017-0682-x","volume":"19","author":"LA Hylton Gravatt","year":"2017","unstructured":"Hylton Gravatt LA, Flurie RW, Lajthia E, Dixon DL (2017) Clinical guidance for managing statin and antimicrobial drug-drug interactions. Curr Atheroscler Rep 19(11):46","journal-title":"Curr Atheroscler Rep"},{"key":"2892_CR25","unstructured":"Jaffe ES (ed) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues, vol 3. Iarc, pp 11\u201316"},{"issue":"12","key":"2892_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00228-004-0858-5","volume":"60","author":"J Kahri","year":"2005","unstructured":"Kahri J, Valkonen M, B\u00e4cklund T, Vuoristo M, Kivist\u00f6 KT (2005) Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. Eur J Clin Pharmacol 60(12):905\u2013907","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"2892_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ajh.25808","volume":"95","author":"GYG Kim","year":"2020","unstructured":"Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG, Stadtmauer EA, Loren AW (2020) Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. Am J Hematol 95(7):792\u2013798","journal-title":"Am J Hematol"},{"issue":"8","key":"2892_CR28","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/512817","volume":"44","author":"DP Kontoyiannis","year":"2007","unstructured":"Kontoyiannis DP (2007) Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis 44(8):1089\u20131090","journal-title":"Clin Infect Dis"},{"issue":"24","key":"2892_CR29","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2017.72.8618","volume":"35","author":"JH Lee","year":"2017","unstructured":"Lee JH, Kim H, Joo YD, Lee WS, Bae SH, Zang DY, Kwon J, Kim MK, Lee J, Lee GW, Lee JH, Choi Y, Kim DY, Hur EH, Lim SN, Lee SM, Ryoo HM, Kim HJ, Hyun MS, Lee KH (2017) Prospective randomized comparison of idarubicin and high-dose daunorubicin in induction chemotherapy for newly diagnosed acute myeloid leukemia. J Clin Oncol 35(24):2754\u20132763","journal-title":"J Clin Oncol"},{"issue":"24","key":"2892_CR30","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.3390\/jcm10245768","volume":"10","author":"YC Li","year":"2021","unstructured":"Li YC, Shih YH, Chen TC, Gau JP, Su YC, Chen MH, Hsu CY, Liao CS, Teng CJ (2021) Redefining remission induction chemotherapy ineligibility by early mortality in de novo acute myeloid leukemia. J Clin Med 10(24):5768. https:\/\/doi.org\/10.3390\/jcm10245768","journal-title":"J Clin Med"},{"key":"2892_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopha.2018.12.076","volume":"111","author":"WG Lima","year":"2019","unstructured":"Lima WG, Alves-Nascimento LA, Andrade JT, Vieira L, de Azambuja Ribeiro RIM, Thom\u00e9 RG, dos Santos HB, Ferreira JMS, Soares AC (2019) Are the statins promising antifungal agents against invasive candidiasis? Biomed Pharmacother 111:270\u2013281","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2892_CR32","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1128\/JCM.42.11.5400-5402.2004","volume":"42","author":"G Luk\u00e1cs","year":"2004","unstructured":"Luk\u00e1cs G, Papp T, Nyilasi I, Nagy E, V\u00e1gv\u00f6lgyi C (2004) Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin. J Clin Microbiol 42(11):5400\u20135402","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2892_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0002-9343(01)01127-5","volume":"112","author":"ML MacMillan","year":"2002","unstructured":"MacMillan ML, Goodman JL, DeFor TE, Weisdorf DJ (2002) Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. Am J Med 112(5):369\u2013379","journal-title":"Am J Med"},{"issue":"1","key":"2892_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","volume":"262","author":"IG Macreadie","year":"2006","unstructured":"Macreadie IG, Johnson G, Schlosser T, Macreadie PI (2006) Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett 262(1):9\u201313","journal-title":"FEMS Microbiol Lett"},{"issue":"11","key":"2892_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11274-021-03158-4","volume":"37","author":"DE Mahmoud","year":"2021","unstructured":"Mahmoud DE, Faraag AHI, Abu El-Wafa WM (2021) In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans. World J Microbiol Biotechnol 37(11):191","journal-title":"World J Microbiol Biotechnol"},{"key":"2892_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1472-6750-13-68","volume":"13","author":"A Maciejak","year":"2013","unstructured":"Maciejak A, Leszczynska A, Warchol I, Gora M, Kaminska J, Plochocka D, Wysocka-Kapcinska M, Tulacz D, Siedlecka J, Swiezewska E, Sojka M, Danikiewicz W, Odolczyk N, Szkopinska A, Sygitowicz G, Burzynska B (2013) The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase. BMC Biotechnol 13:68. https:\/\/doi.org\/10.1186\/1472-6750-13-68","journal-title":"BMC Biotechnol"},{"issue":"5","key":"2892_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1600-0609.2008.01122.x","volume":"81","author":"M Malagola","year":"2008","unstructured":"Malagola M, Peli A, Damiani D, Candoni A, Tiribelli M, Martinelli G, Piccaluga PP, Paolini S, De Rosa F, Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A, Visani G, Skert C, Bergonzi C, Roccaro AM, Fil\u00ec C, Fanin R, Baccarani M, Russo D (2008) Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases. Eur J Haematol 81(5):354\u2013363","journal-title":"Eur J Haematol"},{"issue":"6","key":"2892_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","volume":"84","author":"G Melli","year":"2005","unstructured":"Melli G, Chaudhry V, Cornblath DR (2005) Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 84(6):377\u2013385. https:\/\/doi.org\/10.1097\/01.md.0000188565.48918.41","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2892_CR39","first-page":"943","volume":"48","author":"M Naeimi Eshkaleti","year":"2019","unstructured":"Naeimi Eshkaleti M, Kordbacheh P, Hashemi SJ, Falahati M, Zaini F, Mirhendi H, Safara M, Hosseinpoor L (2019) In vitro activity of amphotericin B in combination with statins against clinical and environmental Rhizopus oryzae strains. Iran J Public Health 48(5):943\u2013948","journal-title":"Iran J Public Health"},{"issue":"2","key":"2892_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1099\/0022-1317-51-2-105","volume":"51","author":"JD Nash","year":"2002","unstructured":"Nash JD, Burgess DS, Talbert RL (2002) Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. J Med Microbiol 51(2):105\u2013109","journal-title":"J Med Microbiol"},{"issue":"4","key":"2892_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.diagmicrobio.2007.10.015","volume":"60","author":"SK Natesan","year":"2008","unstructured":"Natesan SK, Chandrasekar PH, Alangaden GJ, Manavathu EK (2008) Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro. Diagn Microbiol Infect Dis 60(4):369\u2013373","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2892_CR42","unstructured":"NCCN (2023) Prevention and treatment...All right reserved. NCCN.org. Accessed 28 June 2023"},{"issue":"2","key":"2892_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.10.001","volume":"75","author":"D Neofytos","year":"2013","unstructured":"Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, Ostrander D, Nussenblatt V, Karp J (2013) Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis 75(2):144\u2013149","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"2892_CR44","first-page":"140","volume":"52","author":"I Nyilasi","year":"2014","unstructured":"Nyilasi I, Kocsub\u00e9 S, Krizs\u00e1n K, Galg\u00f3czy L, Papp T, Pesti M, Nagy K, V\u00e1gv\u00f6lgyi C (2014) Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Med Mycol 52(2):140\u2013148","journal-title":"Med Mycol"},{"issue":"1","key":"2892_CR45","doi-asserted-by":"publisher","first-page":"22160","DOI":"10.1038\/s41598-021-01716-2","volume":"11","author":"SM Oh","year":"2021","unstructured":"Oh SM, Byun JM, Chang E, Kang CK, Shin DY, Koh Y, Hong J, Kim TS, Choe PG, Park WB, Kim NJ, Yoon SS, Kim I, Oh MD (2021) Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis. Sci Rep 11(1):22160","journal-title":"Sci Rep"},{"issue":"8","key":"2892_CR46","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1182\/blood-2010-03-273243","volume":"117","author":"S Ohtake","year":"2011","unstructured":"Ohtake S, Miyawaki S, Fujita H, Kiyoi H, Shinagawa K, Usui N, Okumura H, Miyamura K, Nakaseko C, Miyazaki Y, Fujieda A, Nagai T, Yamane T, Taniwaki M, Takahashi M, Yagasaki F, Kimura Y, Asou N, Sakamaki H, Handa H, Honda S, Ohnishi K, Naoe T, Ohno R (2011) Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 study. Blood 117(8):2358\u20132365","journal-title":"Blood"},{"issue":"suppl_5","key":"2892_CR47","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1093\/cid\/ciu639","volume":"59","author":"JR Perfect","year":"2014","unstructured":"Perfect JR, Hachem R, Wingard JR (2014) Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis 59(suppl_5):S352\u2013S355","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2892_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/13693780701397673","volume":"45","author":"J Qiao","year":"2007","unstructured":"Qiao J, Kontoyiannis DP, Wan Z, Li R, Liu W (2007) Antifungal activity of statins against Aspergillus species. Med Mycol 45(7):589\u2013593","journal-title":"Med Mycol"},{"issue":"6","key":"2892_CR49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","volume":"49","author":"NdQ Ribeiro","year":"2017","unstructured":"Ribeiro NdQ, Costa MC, Magalh\u00e3es TFF, Carneiro HCS, Oliveira LV, Fontes ACL, Santos JRA, Ferreira GF, Araujo GRdS, Alves V, Frases S, Paix\u00e3o TA, de Resende Stoianoff MA, Santos DA (2017) Atorvastatin as a promising anticryptococcal agent. Int J Antimicrob Agents 49(6):695\u2013702","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2892_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/fgbi.1998.1093","volume":"25","author":"LV Roze","year":"1998","unstructured":"Roze LV, Linz JE (1998) Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus. Fungal Genet Biol 25(2):119\u2013133","journal-title":"Fungal Genet Biol"},{"key":"2892_CR51","doi-asserted-by":"publisher","unstructured":"Saber-Moghaddam N, Azimi SA, Bari A, Arasteh O (2023) Treatment-related acute myeloid leukemia following capecitabine chemotherapy: a case report. JCRMHS 3(3). https:\/\/doi.org\/10.55920\/JCRMHS.2023.03.001114","DOI":"10.55920\/JCRMHS.2023.03.001114"},{"issue":"10147","key":"2892_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE (2018) Acute myeloid leukaemia. Lancet 392(10147):593\u2013606","journal-title":"Lancet"},{"key":"2892_CR53","unstructured":"Society AC (2022) Cancer facts & figures. Atlanta, GA: American Cancer Society 2022"},{"key":"2892_CR54","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (2017) WHO classification of tumours, Revised 4th edn, vol\u00a0 2. WHO, pp 75, 76"},{"issue":"6","key":"2892_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128410","volume":"10","author":"JL Tang","year":"2015","unstructured":"Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, Lin CT, Li CC, Wu SJ, Hou HA, Chou WC, Huang SY, Tsay W, Chen YC, Chen YC, Chang SC, Ko BS, Tien HF (2015) High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a prospective observational study in Taiwan. PLoS ONE 10(6):e0128410","journal-title":"PLoS ONE"},{"key":"2892_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107483","volume":"208","author":"A Tavakkoli","year":"2020","unstructured":"Tavakkoli A, Johnston TP, Sahebkar A (2020) Antifungal effects of statins. Pharmacol Ther 208:107483","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2892_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.12233","volume":"161","author":"O Teuffel","year":"2013","unstructured":"Teuffel O, Leibundgut K, Lehrnbecher T, Alonzo TA, Beyene J, Sung L (2013) Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis. Br J Haematol 161(2):192\u2013203","journal-title":"Br J Haematol"},{"issue":"5","key":"2892_CR58","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1111\/j.1439-0507.2010.01957.x","volume":"54","author":"JN Thompson","year":"2011","unstructured":"Thompson JN, Huycke MM, Greenfield RA, Kurdgelashvili G, Gentry CA (2011) Case\u2013control study of statin prevention of mould infections. Mycoses 54(5):e481\u2013e485","journal-title":"Mycoses"},{"issue":"1","key":"2892_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/eos.12239","volume":"124","author":"M Ting","year":"2016","unstructured":"Ting M, Whitaker EJ, Albandar JM (2016) Systematic review of the in vitro effects of statins on oral and perioral microorganisms. Eur J Oral Sci 124(1):4\u201310","journal-title":"Eur J Oral Sci"},{"issue":"1","key":"2892_CR60","first-page":"58","volume":"15","author":"PA Torres","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD (2015) Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J 15(1):58\u201369","journal-title":"Ochsner J"},{"issue":"3","key":"2892_CR61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1567-1364.2006.00194.x","volume":"7","author":"C Westermeyer","year":"2007","unstructured":"Westermeyer C, Macreadie IG (2007) Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res 7(3):436\u201341. https:\/\/doi.org\/10.1111\/j.1567-1364.2006.00194.x","journal-title":"FEMS Yeast Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02892-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02892-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02892-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T05:06:42Z","timestamp":1716354402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02892-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02892-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3461454\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (reference number: IR.MUMS.REC.1400.095), and registered on the Iranian registry of clinical trials as IRCT20210503051166N1. All participants were explained and informed for protocol of study and signed written consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}